-
1
-
-
0032581450
-
An evaluation of phase i cancer clinical trial designs
-
Ahn, C. (1998). An evaluation of phase I cancer clinical trial designs. Statist. Med. 17:1537-1549.
-
(1998)
Statist. Med.
, vol.17
, pp. 1537-1549
-
-
Ahn, C.1
-
2
-
-
0031920799
-
Cancer phase I clinical trials: Efficient dose escalation with overdose control
-
DOI 10.1002/(SICI)1097-0258(19980530)17:10<1103::AID-SIM793>3.0. CO;2-9
-
Babb, J., Rogatko, A., Zacks, S. (1998). Cancer phase I clinical trials: efficient dose escalation with overdose control. Statist. Med. 17(10):1103-1120. (Pubitemid 28221028)
-
(1998)
Statistics in Medicine
, vol.17
, Issue.10
, pp. 1103-1120
-
-
Babb, J.1
Rogatko, A.2
Zacks, S.3
-
3
-
-
0036712359
-
A simple technique to evaluate model sensitivity in the continual reassessment method
-
Cheung, Y. K., Chappell, R. (2002). A simple technique to evaluate model sensitivity in the continual reassessment method. Biometrics 58(3):671-674.
-
(2002)
Biometrics
, vol.58
, Issue.3
, pp. 671-674
-
-
Cheung, Y.K.1
Chappell, R.2
-
4
-
-
0027319907
-
The continual reassessment method in cancer phase i clinical trials: A simulation study
-
Chevret, S. (1993). The continual reassessment method in cancer phase I clinical trials: A simulation study. Statist. Med. 12:1093-1108.
-
(1993)
Statist. Med.
, vol.12
, pp. 1093-1108
-
-
Chevret, S.1
-
5
-
-
0028060511
-
Practical modifications of the continual reassessment method for phase i cancer clinical trials
-
Faries, D. (1994). Practical modifications of the continual reassessment method for phase I cancer clinical trials. J. Biopharm. Statist. 4(2):147-164.
-
(1994)
J. Biopharm. Statist.
, vol.4
, Issue.2
, pp. 147-164
-
-
Faries, D.1
-
6
-
-
0028170238
-
A comparison of two phase i trial designs
-
Korn, E. L., Midthune, D., Chen, T. T., Rubinstein, L. V., Christian, M. C., Simon, R. M. (1994). A comparison of two phase I trial designs. Statist. Med. 13(18):1799-1806.
-
(1994)
Statist. Med.
, vol.13
, Issue.18
, pp. 1799-1806
-
-
Korn, E.L.1
Midthune, D.2
Chen, T.T.3
Rubinstein, L.V.4
Christian, M.C.5
Simon, R.M.6
-
7
-
-
67649321803
-
Model calibration in the continual reassessment method
-
Lee, S. M., Cheung, Y. K. (2009). Model calibration in the continual reassessment method. Clin. Trials 6(3):227-238.
-
(2009)
Clin. Trials
, vol.6
, Issue.3
, pp. 227-238
-
-
Lee, S.M.1
Cheung, Y.K.2
-
8
-
-
33746883844
-
A phase i dose-finding and pharmacokinetic study of subcutaneous semisynthetic homoharringtonine (ssHHT) in patients with advanced acute myeloid leukaemia
-
Aug 7
-
Lévy, V., Zohar, S., Bardin, C., Vekhoff, A., Chaoui, D., Rio, B., Legrand, O., Sentenac, S., Rousselot, P., Raffoux, E., Chast, F., Chevret, S., Marie, J. P. (2006, Aug 7). A phase I dose-finding and pharmacokinetic study of subcutaneous semisynthetic homoharringtonine (ssHHT) in patients with advanced acute myeloid leukaemia. Br. J. Cancer 95(3):253-259.
-
(2006)
Br. J. Cancer
, vol.95
, Issue.3
, pp. 253-259
-
-
Lévy, V.1
Zohar, S.2
Bardin, C.3
Vekhoff, A.4
Chaoui, D.5
Rio, B.6
Legrand, O.7
Sentenac, S.8
Rousselot, P.9
Raffoux, E.10
Chast, F.11
Chevret, S.12
Marie, J.P.13
-
9
-
-
0033619523
-
Another look at two phase i clinical trial designs
-
O'Quigley, J. (1999). Another look at two phase I clinical trial designs. Statist. Med. 18(20):2683-2690.
-
(1999)
Statist. Med.
, vol.18
, Issue.20
, pp. 2683-2690
-
-
O'Quigley, J.1
-
10
-
-
27744594554
-
Retrospective analysis of sequential dose-finding designs
-
O'Quigley, J. (2005). Retrospective analysis of sequential dose-finding designs. Biometrics 61(3):749-756.
-
(2005)
Biometrics
, vol.61
, Issue.3
, pp. 749-756
-
-
O'Quigley, J.1
-
11
-
-
0029938415
-
Continual reassessment method: A likelihood approach
-
O'Quigley, J., Shen, L. Z. (1996). Continual reassessment method: a likelihood approach. Biometrics 52(2):673-684.
-
(1996)
Biometrics
, vol.52
, Issue.2
, pp. 673-684
-
-
O'Quigley, J.1
Shen, L.Z.2
-
12
-
-
33644840022
-
Experimental designs for phase i and phase I/II dose-finding studies
-
O'Quigley, J., Zohar, S. (2006). Experimental designs for phase I and phase I/II dose-finding studies. Br. J. Cancer 94(5):609-613.
-
(2006)
Br. J. Cancer
, vol.94
, Issue.5
, pp. 609-613
-
-
O'Quigley, J.1
Zohar, S.2
-
13
-
-
1142304984
-
Non-parametric optimal design in dose finding studies
-
O'Quigley, J., Paoletti, X., Maccario, J. (2002). Non-parametric optimal design in dose finding studies. Biostatistics 3:51-56.
-
(2002)
Biostatistics
, vol.3
, pp. 51-56
-
-
O'Quigley, J.1
Paoletti, X.2
MacCario, J.3
-
14
-
-
0025148278
-
Continual reassessment method: A practical design for phase 1 clinical trials in cancer
-
O'Quigley, J., Pepe, M., Fisher, L. (1990). Continual reassessment method: A practical design for phase 1 clinical trials in cancer. Biometrics 46(1):33-48.
-
(1990)
Biometrics
, vol.46
, Issue.1
, pp. 33-48
-
-
O'Quigley, J.1
Pepe, M.2
Fisher, L.3
-
15
-
-
33746402001
-
Consistency of continual reassessment method under model misspecification
-
Shen, L. Z., O'Quigley, J. (1996). Consistency of continual reassessment method under model misspecification. Biometrika 83:395-405.
-
(1996)
Biometrika
, vol.83
, pp. 395-405
-
-
Shen, L.Z.1
O'Quigley, J.2
-
16
-
-
0031670630
-
Bayesian decision procedures based on logistic regression models for dose-finding studies
-
Whitehead, J., Williamson, D. (1998). Bayesian decision procedures based on logistic regression models for dose-finding studies. J. Biopharm. Statist. 8(3):445-467.
-
(1998)
J. Biopharm. Statist.
, vol.8
, Issue.3
, pp. 445-467
-
-
Whitehead, J.1
Williamson, D.2
|